The TNF signaling pathway has been suggested as a therapeutic target for general CKD (Al-Lamki and Mayadas, 2015; Breyer and Susztak, 2016), autoimmune diseases, and cancers (Shaikh et al., 2018; Steeland et al., 2018). This evidence concerns the gene TNF and chronic kidney disease.